BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24965844)

  • 1. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study.
    Frambo AA; Atashili J; Fon PN; Ndumbe PM
    BMC Res Notes; 2014 Jun; 7():394. PubMed ID: 24965844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka Health Districts of the South West region of Cameroon: a three-year retrospective study.
    Eyong EM; Yankam BM; Seraphine E; Ngwa CH; Nkfusai NC; Anye CS; Nfor GK; Cumber SN
    Pan Afr Med J; 2019; 32():122. PubMed ID: 31312290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon.
    Noubiap JJ; Nansseu JR; Ndoula ST; Bigna JJ; Jingi AM; Fokom-Domgue J
    BMC Public Health; 2015 May; 15():454. PubMed ID: 25933803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon.
    Ndzie Ondigui JL; Mafopa Goumkwa N; Lobe C; Wandji B; Awoumou P; Voussou Djivida P; Peyonga P; Manju Atah S; Verbe V; Kamgaing Simo R; Moudourou SA; Gutierrez A; Garcia R; Fernandez I; Riwom Essama SH; Mbu R; Torimiro J
    PLoS One; 2024; 19(6):e0287491. PubMed ID: 38900729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
    Ekouevi DK; Larrouy L; Gbeasor-Komlanvi FA; Mackiewicz V; Tchankoni MK; Bitty-Anderson AM; Gnatou GY; Sadio A; Salou M; Dagnra CA; Descamps D; Coffie PA
    BMC Infect Dis; 2020 Nov; 20(1):839. PubMed ID: 33183254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon?
    Fomulu NJ; Morfaw FL; Torimiro JN; Nana P; Koh MV; William T
    BMC Pregnancy Childbirth; 2013 Aug; 13():158. PubMed ID: 23924215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission.
    Amsalu A; Ferede G; Eshetie S; Tadewos A; Assegu D
    J Pregnancy; 2018; 2018():8435910. PubMed ID: 30174956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon.
    Kfutwah AK; Tejiokem MC; Njouom R
    Virol J; 2012 Mar; 9():62. PubMed ID: 22401702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women.
    Aba HO; Aminu M
    Ann Afr Med; 2016; 15(1):20-7. PubMed ID: 26857933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon.
    Molu JP; Essome MCN; Monamele CG; Njouom R
    BMC Res Notes; 2018 Jan; 11(1):39. PubMed ID: 29338763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon.
    Ducancelle A; Abgueguen P; Birguel J; Mansour W; Pivert A; Le Guillou-Guillemette H; Sobnangou JJ; Rameau A; Huraux JM; Lunel-Fabiani F
    PLoS One; 2013; 8(11):e80346. PubMed ID: 24265811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional study.
    Manyahi J; Msigwa Y; Mhimbira F; Majigo M
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):109. PubMed ID: 28388879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study.
    Mpody C; Thompson P; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
    PLoS One; 2019; 14(5):e0216293. PubMed ID: 31071145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia.
    Umare A; Seyoum B; Gobena T; Haile Mariyam T
    PLoS One; 2016; 11(11):e0166936. PubMed ID: 27898721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study.
    Zenebe Y; Mulu W; Yimer M; Abera B
    BMC Infect Dis; 2014 Mar; 14():118. PubMed ID: 24580859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study.
    Metaferia Y; Dessie W; Ali I; Amsalu A
    Epidemiol Health; 2016; 38():e2016027. PubMed ID: 27336446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria.
    Adegbesan-Omilabu MA; Okunade KS; Gbadegesin A; Olowoselu OF; Oluwole AA; Omilabu SA
    Niger J Clin Pract; 2015; 18(6):819-23. PubMed ID: 26289525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.